RxDoctor Payments Data

Paul Gilman

Hematology & Oncology · Wynnewood, PANPI 1215943634

Payments from drug & device makers

$480,648in general payments, 2019–2025

Across 151 payments — averaging $3183.10 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Tolmar, Inc.$135K
  • Merck$127K
  • Sanofi US Services Inc.$71K
  • Genentech, Inc.$46K
  • GSK$34K
  • Radius Health, Inc.$22K
  • plus $45K from 13 others
$2,758in research payments, 2019–2025

Across 1 payment — averaging $2757.76 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Eli Lilly$3K

What the payments were for

  • Food & beverage$68181%
  • Education$15919%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$480,648 in reported general payments places this provider in the 85th percentile of 682 hematology & oncology providers in Pennsylvania.

See all hematology & oncology providers in Pennsylvania

Other hematology & oncology in Wynnewood

See the full list for Pennsylvania

Where these figures come from

Is this you, or does something look wrong? →